HISTORIC MOU SIGNED FOR MAJOR NEW RESEARCH PROGRAM FOR CANNABIS-BASED MEDICINES FOR PAEDIATRIC EPILEPSY
Tuesday, 27 October 2015Member of the Legislative Council Natasha Maclaren-Jones today welcomed the NSW Government’s announcement that a Memorandum of Understanding (MOU) has been signed with GW Pharmaceuticals (GW) to progress a major new research program for cannabis-based medicines in children with severe, drug resistant paediatric epilepsy.
Mrs Maclaren-Jones said many children are suffering and this announcement provides hope for families.